Provider Resources
Provider Onboarding Timeline
From application to first prescription. Steps, expected turnaround, and what we ask for at each stage.
Typical end-to-end timing. Most prescribers go from application to first prescription in under two weeks. The application itself takes ten minutes; the rest is licensure verification and a partnership conversation.
Step 1: Submit the application
Complete the form at /apply. The application captures basic practice information (name, type of practice, NPI, DEA, state licensure, malpractice carrier) plus a short note on the kinds of compounds you currently prescribe or are interested in. The form is short on purpose. We confirm specifics in the follow-up conversation.
Step 2: Admin review
Our admin team reviews the application against the licensure footprint and confirms no obvious blockers. Most reviews complete within one to three business days. If we need additional documentation (a clearer copy of a license, a confirmation of a specialty, a DEA addendum), we email rather than reject.
Step 3: Approval and account creation
On approval, you receive an email invitation to set a password and finish creating your prescriber account. The account is where pricing, formulary detail, and order workflow live once the rest of the platform comes online.
Step 4: Partnership conversation
Before any prescriptions flow, our team schedules a short call to walk through the partnership: workflow expectations, the current formulary, pricing tiers, the cold-chain logistics, and anything specific to your practice (multi-prescriber setup, unique compounds, integration with an existing patient base).
Step 5: First prescription
With the partnership conversation closed, you can write your first prescription. The companion article on writing your first compounded prescription covers exactly what we need on the script and where to send it.
Documents to have ready
You do not need these to submit the application, but having them on hand speeds the review:
- State medical or nursing license number(s) and expiration.
- NPI number.
- DEA registration if applicable to your prescribing scope.
- Malpractice insurance carrier and policy number.
- Practice address(es) where prescriptions originate.
What we are NOT asking for at onboarding
- Patient lists or any patient-identifying information.
- EMR data exports.
- Practice financial information beyond what is on the application.
- An exclusive partnership commitment.
Frequently asked questions
- Can I onboard a multi-prescriber practice at once?
Yes. Each prescriber submits their own application so we have verified licensure information for everyone, but the conversations about partnership terms and workflow can happen at the practice level. Tell us up front and we will coordinate.
- Do you verify NPI / DEA against a primary source?
At MVP we collect NPI and DEA on the application and our admin team manually reviews each application. NPPES registry lookup as part of the automated review pipeline is on the roadmap.
- What happens if my application is rejected?
Rejections are rare and almost always come down to a missing license, a state we are not licensed to ship to, or scope mismatch (the practice is not a fit for compounded medications). The rejection email includes a reason. You can reapply once the underlying issue is resolved.
- How long until I can write my first prescription?
Once approved, prescriptions can flow as soon as the partnership conversation closes. For most prescribers that is the same week as approval.
Disclaimer
General educational reference. Not medical advice.
The information on this page is published for general educational purposes. It is not a substitute for medical advice, diagnosis, or treatment. Always follow the specific instructions provided by your prescribing clinician, and consult them before changing how you take any compounded medication.
Crystal Clear RX Wellness is not a pharmacy. Compounded medications are prepared by a licensed 503A compounding pharmacy partner pursuant to a valid prescription written by a licensed clinician for an individually identified patient. A licensed prescriber must evaluate your eligibility before any compounded medication is dispensed. The therapies referenced on this page are not FDA-approved drugs; they are compounded formulations prepared at the discretion of the prescribing clinician under section 503A of the Food, Drug, and Cosmetic Act.
References to USP guidance, beyond-use dating, or technique norms reflect generally accepted practice for at-home subcutaneous self-administration. They do not override prescriber-specific instructions, product labeling, or the policies of your dispensing pharmacy.
For full regulatory information, see the 503A disclosure.